Regulatory Hurdles Cleared: What ABx’s Radiological Exemption Means for Investors
ABx Group’s maiden mixed rare earth carbonate from Tasmania’s Deep Leads resource has been confirmed radiologically safe by ANSTO, with a second, higher-grade sample expected soon. The development could open doors to key international customers and reduce regulatory complexities.
- Maiden mixed rare earth carbonate (MREC) exempt from radiological control
- Dysprosium and terbium content 2.8 to 4.7 times higher than peers
- Basket price 17% to 51% above comparable products
- Second MREC sample produced with assay results due in March 2026
- Samples dispatched to potential customers including Ucore Rare Metals
Radiological Safety Confirmed for Maiden Product
ABx Group Limited (ASX: ABX) has reached a significant milestone with its maiden mixed rare earth carbonate (MREC) product sourced from the Deep Leads ionic clay rare earth deposit in northern Tasmania. The Australian Nuclear Science and Technology Organisation (ANSTO) has confirmed that this initial batch meets the International Atomic Energy Agency’s exemption criteria for radiological control. This is a notable achievement given that many rare earth deposits contain uranium and thorium, which complicate processing and regulatory compliance.
By demonstrating that its product is essentially free of these radioactive elements, ABx not only simplifies potential regulatory hurdles but also enhances the appeal of its rare earth concentrate to a broader range of customers and processors who often reject radioactive feedstocks.
Superior Rare Earth Composition and Market Potential
The maiden MREC boasts a dysprosium and terbium content between 2.8 and 4.7 times higher than comparable products from peer companies, translating into a basket price premium ranging from 17% to 51%. Dysprosium and terbium are critical heavy rare earth elements prized for their use in permanent magnets and advanced technologies, making ABx’s product particularly valuable in the global supply chain.
Samples of this maiden product have already been dispatched to multiple prospective customers, including Ucore Rare Metals Inc., a North American company planning to develop rare earth processing facilities. ABx’s existing Memorandum of Understanding with Ucore underscores the strategic intent to supply mixed rare earth carbonates into Western markets, which are actively seeking secure and ethically sourced rare earth materials.
Second Sample Expected to Outperform Maiden Batch
Building on the initial success, ABx has produced a second MREC sample using liquor from recent column leach tests. This batch, weighing approximately 120 grams, is anticipated to have an even higher heavy rare earth content and lower impurities. Assay results are expected in March 2026, and positive outcomes could further strengthen ABx’s market position and customer interest.
The availability of a second sample will also enable ABx to broaden its outreach to additional potential customers, accelerating commercial discussions and partnerships.
Strategic Engagement in North America
ABx’s Managing Director, Dr Mark Cooksey, is currently part of an Australian Critical Minerals delegation attending the PDAC Convention in Toronto and a business matchmaking session in New York. These engagements aim to deepen relationships with international customers, investors, and government agencies, positioning ABx as a key player in the critical minerals sector.
Dr Cooksey highlighted the competitive advantage of ABx’s low-radioactivity product and expressed optimism about forthcoming customer feedback and discussions during the North American trip.
Next Steps and Outlook
ABx is advancing economic and metallurgical studies to optimise project design, supported by collaborations with ANSTO and engineering partners. These efforts will underpin the company’s pathway to commercialisation and supply chain integration.
With regulatory risks mitigated and product quality confirmed, ABx is well positioned to capitalise on growing demand for heavy rare earths critical to clean energy and advanced technology sectors.
Bottom Line?
As ABx awaits second sample assays and customer feedback, its rare earth project edges closer to commercial reality with reduced regulatory risk.
Questions in the middle?
- Will the second MREC sample confirm the anticipated higher heavy rare earth content?
- How will potential customers respond to the maiden MREC’s quality and radiological exemption?
- What commercial agreements or partnerships might emerge from ABx’s North American business development efforts?
